Corrigendum: Randomized, crossover questionnaire survey of acceptabilities of controlled-release mesalazine tablets and granules in ulcerative colitis patients

https://doi.org/10.5217/ir.2018.00078

Intest Res 2019;17(1):87-93

In the version of this article initially published, Figure 2 contains errors in the content of the questionnaire.

On page 89, the figure should be corrected as following.

From:

Fig. 2.

(A) Questionnaire 1: acceptability of tablets. (B) Questionnaire 2: acceptability of granules. (C) Questionnaire 3: comparison of tablets and granules. All the original questionnaires were written in Japanese. CR, controlled-release.

To:

Fig. 2.

(A) Questionnaire 1: acceptability of tablets. (B) Questionnaire 2: acceptability of granules. (C) Questionnaire 3: comparison of tablets and granules. All the original questionnaires were written in Japanese. CR, controlled-release.